Quercetin

angiotensin converting enzyme 2 ; Homo sapiens







17 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35060921 Inhibitory effects of specific combination of natural compounds against SARS-CoV-2 and its Alpha, Beta, Gamma, Delta, Kappa, and Mu variants. 2022 Feb 3 1
2 35624740 The Therapeutic and Prophylactic Potential of Quercetin against COVID-19: An Outlook on the Clinical Studies, Inventive Compositions, and Patent Literature. 2022 Apr 29 1
3 32698689 Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an in silico study for drug development. 2021 Oct 1
4 32957884 Quercetin and its Relative Therapeutic Potential Against COVID-19: A Retrospective Review and Prospective Overview. 2021 1
5 33444408 Quercetin as a potential treatment for COVID-19-induced acute kidney injury: Based on network pharmacology and molecular docking study. 2021 1
6 33459225 Natural Agents Modulating ACE-2: A Review of Compounds with Potential against SARS-CoV-2 Infections. 2021 2
7 33520683 Anti-COVID-19 drug candidates: A review on potential biological activities of natural products in the management of new coronavirus infection. 2021 Mar 1
8 33847382 Potential antiviral activity of isorhamnetin against SARS-CoV-2 spike pseudotyped virus in vitro. 2021 Dec 1
9 34574194 Consumption of Phenolic-Rich Food and Dietary Supplements as a Key Tool in SARS-CoV-19 Infection. 2021 Sep 3 1
10 34607208 In silico identification of SARS-CoV-2 cell entry inhibitors from selected natural antivirals. 2021 Dec 1
11 34824739 Molecular Docking and ADMET Prediction of Natural Compounds towards SARS Spike Glycoprotein-Human Angiotensin-Converting Enzyme 2 and SARS-CoV-2 Main Protease. 2021 Summer 1
12 34931597 In silico study of potential immunonutrient-based sports supplements against COVID-19 via targeting ACE2 inhibition using molecular docking and molecular dynamics simulations. 2021 Dec 21 1
13 32593613 Testing of natural products in clinical trials targeting the SARS-CoV-2 (Covid-19) viral spike protein-angiotensin converting enzyme-2 (ACE2) interaction. 2020 Aug 2
14 32643448 Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19. 2020 Aug 2
15 32656311 Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor. 2020 Jun 2
16 33179911 Quercetin and Its Metabolites Inhibit Recombinant Human Angiotensin-Converting Enzyme 2 (ACE2) Activity. 2020 Nov 25 2
17 33200026 Chinese herbal compounds against SARS-CoV-2: Puerarin and quercetin impair the binding of viral S-protein to ACE2 receptor. 2020 3